PK assessors variability [Bioanalytics]

posted by Obinoscopy  – USA, 2020-07-17 23:48 (435 d 08:29 ago) – Posting: # 21735
Views: 3,307

Hi Ohlbe,

» In Europe: add the between-country variability. In the US: possibly a between-review-division variability ?

:-D

I wonder the study design we can use to measure these variabilities...especially the variability within the USFDA.

But this is sad...I had thought standardization and uniformity of regulatory review methods should be one of the foundation of regulatory science.

Scopy

Complete thread:

Activity
 Admin contact
21,700 posts in 4,538 threads, 1,542 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Sunday 08:18 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5